Pasar al contenido principal

MEJORA DE LAS CONDICIONES DE PRODUCCIÓN EN EXPLOTACIONES APÍCOLAS, IMPACTO DE TRATAMIENTOS VETERINARIOS EN GESTIÓN CONVENCIONAL, E INDICADORES DE BIENESTAR DE LA COLONIA

PRE2018-084048

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO NACIONAL DE INVESTIGACIÓN Y TECNOLOGÍA AGRARIA Y ALIMENTARIA - CSIC

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Coumaphos residue transfer to honey bee brood (Apis mellifera) in realistic scenarios

  • Luna, Alba
  • Colmenero Flores, José M.
  • Miguel Gómez, María Esther
  • Fernández-Alba, Antonio R.
  • Hernando Guil, María Dolores
19 Pág., Coumaphos is a veterinary treatment administered for the control of Varroa destructor in honey bee colonies. The detection of its residues, however, has been frequently reported in beeswax. This study is pioneer to investigate whether the honey bee brood is exposed to coumaphos via contact or by ingestion of food resources due to a residue transfer inside the bee hive. This field study addresses two scenarios: 1) after its administration according to the posology using strips inside the bee hives and, 2) placing contaminated wax containing coumaphos at 10 mg/Kg into the bee hives (simulating the use of recycled wax). In bee bread, the average concentrations of residues (mean ± s.d.) were 246.66 ± 772.29 ng/g and 192.55 ± 320.19 ng/g in scenario 1 and 2, respectively. In honey, residue concentration was 1.98 ± 5.41 ng/g and 1.93 ± 6.59 ng/g. In scenario 2, exposure has led to residue detection in all larval stages at concentrations ranging from 51.93 to 383.42 ng/g (larvae), 42.20-58.54 ng/g (prepupae), 18.35-26.24 ng/g (pupae) to 21.92-35.92 ng/g (born bee). This study shows that there is a high risk for the bee brood (larvae) by ingestion of bee bread when the residue concentration is >251.31 ng/g. Residue levels in larvae or in prepupae >42.20 ng/g give rise to a moderate risk., This work was supported by the MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” under Grant RTA2017-00058-C4; and MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future” under Grant PRE2018-084048., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Risk assessment of veterinary treatments in bee brood and adult honey bees

  • Luna, Alba
  • Colmenero Flores, José M.
  • Alonso, Raúl
  • Miguel Gómez, María Esther
  • Fernández-Alba, Antonio R.
  • Hernando Guil, María Dolores
Amitraz and tau-fluvalinate are veterinary treatments administered for the control of Varroa destructor in honey bee colonies. These treatments can generate harmful residues for bees. This field study addresses the issue under two scenarios: 1) administration according to the posology and 2) placing contaminated wax containing the treatments. Tau-fluvalinate (Apistan®) residues were detected in larval stages from 25.34 to 84.72 ng g−1 in scenario 1 and from 29.63 to 173.97 ng g−1 in scenario 2. In addition, it was detected in bee bread in scenario 2 from 55.72 to 573.79 ng g−1. In scenario 1, DMPF + DMF (amitraz metabolites) were found from 37.09 to 171.58 ng g−1 (Amicel®) and from 36.74 to 42.64 ng g−1 (Apivar®) in bee bread. In honey, DMPF + DMF ranged from 19.96 to 145.30 ng g−1 (Amicel®) and from 32.20 to 78.43 ng g−1 from (Apivar®). With these treatments, a significant reduction in the population of Varroa mites (mean ± s.d.) was observed between 95.15 ± 2.56% and 98.29 ± 1.97%. There were significant positive correlations between Amicel®, the population of adult bees and the population of brood during evaluation 2 showing a higher effectiveness. According to both RQ (Risk Quotient) and SRA (Standard Risk Approach) values for adult bees and larvae, there is no risk when considering exposure by contact or by ingestion of bee bread or honey. In scenario 2, there is no risk for most of the larval stages, except in two bee hives treated with tau-fluvalinate, where the SRA values were 1.73 and 1.29%, indicating a moderate risk due to acute oral exposure., This work was supported by the MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” under Grant RTA2017-00058-C4; and MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” under Grant PRE2018-084048., Peer reviewed